Understanding the genetic makeup of canine cancer tumors, and comparing their genetic makeup to those of people with cancer, will allow researchers to discover additional targeted drug therapies and the
least toxic
doses of those therapies that are most
effective in curing the individual, whether canine or human.
If antidepressant medications are indicated for dually diagnosed patients, the findings that they can be
effective (when used at adequate
doses for at
least six weeks) in people accurately diagnosed with major depression or dysthymia are clinically relevant.